Omic­Scouts GmbH

Omic­Scouts GmbH, based in Fre­is­ing, Ger­many, is a glob­al lead­er in mass spec­tro­metry-based pro­teo­m­ics, com­bin­ing excel­lent research expert­ise and innov­at­ive tech­no­lo­gies for drug and bio­mark­er dis­cov­ery. Omic­Scouts devel­ops pro­teo­me-wide assays that work with nat­ive pro­teins in a physiolo­gic­al set­ting to identi­fy small molecule drug tar­gets, tar­get engage­ment mark­ers, molecu­lar mech­an­isms of action and drug response bio­mark­ers. The com­pany brings its expert­ise in (chem­ic­al) pro­teo­m­ics, com­pu­ta­tion­al bio­logy, sys­tems bio­logy and sys­tems phar­ma­co­logy to the network.